The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.

The usual dose of Novo Nordisk’s expensive weight-loss drug Wegovy can be cut in half without affecting the results, ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

A new study found users of one drug lost almost 50 percent more weight that users of Wegovy. People taking Eli Lilly’s ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

The Royal College of GPs’ weight loss expert has sounded a warning bell for users of popular drugs Ozempic, Mounjaro and ...

Both medications were prescribed as weekly injections for patients clinically classified as obese, and were recommended ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...